Literature DB >> 6607257

Growth factor-induced proliferation of human fibroblasts in serum-free culture depends on cell density and extracellular calcium concentration.

C Betsholtz, B Westermark.   

Abstract

Human neonatal skin fibroblasts plated sparsely in MCDB 105 traversed a complete cell cycle in the absence of serum or serum-derived proteins. Addition of pure PDGF did not significantly increase entrance into S phase as revealed by 3H-thymidine labeling index or clonal growth on palladium islands. In subphysiologic Ca2+ concentrations or in the presence of a calmodulin inhibitor, W7, proliferation in the absence of growth factors ceased and PDGF became mitogenic. In contrast, confluent fibroblast cultures were stimulated by PDGF in physiologic Ca2+ concentrations. This was also the case with sparse adult skin fibroblast cultures while a fetal strain entered S in the absence of PDGF even in low extracellular Ca2+ concentrations. EGF gave similar results as PDGF in all experiments performed. This proposes a similar role for the two growth factors in the cell cycle. However, a difference in the mechanisms of action of PDGF and EGF is indicated by the fact that PDGF and EGF were additive at optimal concentrations when maximal growth response by a single growth factor was restricted by a subphysiologic extracellular Ca2+ concentration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607257     DOI: 10.1002/jcp.1041180213

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  A novel physiological function for platelet-derived growth factor-BB in rat dermis.

Authors:  S A Rodt; K Ahlén; A Berg; K Rubin; R K Reed
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

2.  Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product.

Authors:  A Johnsson; C Betsholtz; K von der Helm; C H Heldin; B Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

3.  The A-type receptor for platelet-derived growth factor mediates protein tyrosine phosphorylation, receptor transmodulation and a mitogenic response.

Authors:  A Hammacher; M Nistér; C H Heldin
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

4.  The growth of WI-38 cells in a serum-free, growth factor-free, medium with elevated calcium concentrations.

Authors:  F C Praeger; V J Cristofalo
Journal:  In Vitro Cell Dev Biol       Date:  1986-06

5.  Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects.

Authors:  M Bywater; F Rorsman; E Bongcam-Rudloff; G Mark; A Hammacher; C H Heldin; B Westermark; C Betsholtz
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

6.  Alterations of excitation-contraction coupling by platelet-derived growth factor in enzymatically isolated and cultured vascular smooth muscle cells.

Authors:  K G Morgan; T T DeFeo; K Wenc; R Weinstein
Journal:  Pflugers Arch       Date:  1985-09       Impact factor: 3.657

7.  Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha.

Authors:  I Lax; A Johnson; R Howk; J Sap; F Bellot; M Winkler; A Ullrich; B Vennstrom; J Schlessinger; D Givol
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  Retinoic acid stimulation of human dermal fibroblast proliferation is dependent on suboptimal extracellular Ca2+ concentration.

Authors:  J Varani; J Shayevitz; D Perry; R S Mitra; B J Nickoloff; J J Voorhees
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

Review 9.  Platelet-derived growth factor as a mediator of normal and neoplastic cell proliferation.

Authors:  B Westermark; C H Heldin
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

Review 10.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.